Cambridge Investment Research Advisors’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
PAIM
GJL
NC
VC
JCP
PCM
RA
Cambridge Investment Research Advisors's BXC Position: Q1 2022 in Review
Cambridge Investment Research Advisors sold out of BlueLinx (BXC) in Q1 2022, closing a stake of 2,874 shares — an estimated $275K sold.
Cambridge Investment Research Advisors first reported a position in BXC in Q4 2021 and held it in 1 quarter. The position peaked at $275K in Q4 2021. 163 funds tracked by Wall St. Rank hold BXC as of Q1 2022.
- Cambridge Investment Research Advisors reported no remaining BlueLinx position as of Q1 2022 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 2,874 BlueLinx shares in Q1 2022, an estimated $275K.
- Cambridge Investment Research Advisors first reported a position in BlueLinx in Q4 2021 and held it in 1 quarter.
- Cambridge Investment Research Advisors's BlueLinx position peaked at $275K in Q4 2021.
- 163 funds tracked by Wall St. Rank held BlueLinx as of Q1 2022.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.